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Analytical Method Life Cycle
• What is the final aim of quantitative analytical 
methods ?
– Start with the end !
– Objective: provide results used to make decisions
• Release of a batch
• Stability/Shelf life
• Patient health
• PK/PD studies, …
• What matters are the results produced by the 
method.
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Analytical Method Life Cycle
• Need to demonstrate/guarantee that the 
analytical method will provide, in its future 
routine use, quality results
• This is the key aim of Analytical Method 
Validation !
How ?
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Analytical Method Validation
• Traditional vision:
– The Validation Criteria Check List:
• Selectivity 
• Trueness/Mean Accuracy
• Precision
• Linearity
• Range
• Limit of Quantification (LOQ)
Method Valid !
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Analytical Method Validation
• Traditional vision:
– Is a valid method providing reliable results ?
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Analytical Method
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Aim of validation
Is to give to laboratories as well as to regulatory agencies
the guaranties that each result that will be obtained in 
routine will be close enough to the unknown true value of
the analyte in the sample.
Analytical Method Validation
[ ] minpiλpi ≥<−= Ti µXP
πmin= minimum probability that a 
result will be included inside ± λ
λ= predefined acceptance limits
λµ −T λµ +Tµ
pi
E. Rozet et al., J. Chromatogr.A, 1158 (2007) 126
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Series 2
Series J
Validation standards
K repetitions
Typical Validation Design
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Typical Statistical Model
• By concentration level i:
– One Way Random ANOVA model
– Intermediate Precision variance
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Reliability Probability Estimator 1 – piBetii
• Based on β-expectation tolerance
intervals:
Allows to predict where
each future result will fall
(Wald, 1942).
λµ −T λµ +Tµ
β
Acceptance Limits
Tolerance Interval
 If the β-expectation tolerance interval is included
inside the acceptance limits, then the probability that
each future result will be within the acceptance limits
is at least β (ex. 80%).
B. Boulanger et al., J. Chromatogr. B, 877 (2009) 2235
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Reliability Probability Estimator 1 – piBetii
• Based on β-expectation tolerance
intervals:
Beti
ipi
λµ −T λµ +Tµ
Acceptance Limits
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Reliability Probability Estimator 1 – piBetii
• Based on β-expectation tolerance
intervals:
• N=JK.  
• is the mean results 
• t(f): Student distribution with f degrees of freedom using 
Satterthwaite approximation 
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Reliability Probability Estimator 2 – piMLi
• Maximum likelihood estimator
where Z is a standard normal variable.
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Bayesian Reliability Estimator - pi
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• Aims: modeling the reliability probability over the whole 
concentration range
• Model: Linear model with random slopes and intercepts
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Simulations
• 4 scenarios:
– Conditions
• Analytical Method relative bias: 0% and 10%
• Analytical Method I.P. RSD: 6.5% and 16%
• Known concentrations (µT,i):60%, 80%, 100% and 120%
• Acceptance limits: λ=±20%
• Nb Series: J=4
• Nb Repetitions: K=4
– Criteria
• Compare median estimated reliability probabilities to true
probability
• Compare ranges (min to max) of estimated reliability
probabilites
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Case 1: 0% bias – 16.0% RSD
Median values
True pi
piML
pi
piBetipipiML
piBeti
Ranges
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Case 2: 10% bias – 16.0% RSD
pi
piML piBeti
Ranges
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Case 3: 0% bias – 6.5% RSD
pi
piML
piBeti
Ranges
10
19
Case 4: 10% bias – 16.0% RSD
pi
piML
piBeti
Ranges
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Example of application
• Validation of a bioanalytical method:
– SPE-HPLC-UV method for the quantification of
ketoglutaric acid (KG) and hydroxymethylfurfural
(HMF) in human plasma
• Known concentrations (µT,i): 0.13, 0.67, 3.33, 66.67 and 
133.33 µg/ml
• Nb Series: J=3
• Nb Repetitions: K=4
• Acceptance limits: λ=±20%
• Minimum reliability probability: pimin=0.90
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Ketoglutaric acid
LOQ
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Hydroxymethylfurfural
LOQ
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Conclusions
 Switch from the traditional check list validation to a 
rewarding, useful and predictive method validation
 The quality of future results (pi) must be the objective of 
method validation and not the past performances of the 
method.
 The Bayesian reliability probability estimator is less biased
and more precise.
 In such a way, the risks are known at the end of the 
validation.
 This decision methodology is fully compliant with actual 
regulatory requirements
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Thanks for your attention
• Check our publications at:
http://orbi.ulg.ac.be/
• Contact:
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